| VITROLIFE AB SK 0,2 |
| Schweden |
| Gesundheit |
| SE0011205202 / A2JLT3 |
| VTFN (Frankfurt) |
| FRA:VTFN, ETR:VTFN, VTFN:GR |
| - |
| https://www.vitrolife.com.. |
|
Vitrolife AB is a leading global provider of medical devices and genetic testing services dedicated to the reproductive-health market, specializing in assisted reproduction technologies. The company develops, manufactures, and distributes specialized..
>Volltext.. |
| 1133.94 Mio. EUR |
| 1206.5 Mio. EUR |
| 318.66 Mio. EUR |
| 96.74 Mio. EUR |
| -464.32 Mio. EUR |
| -3.43 EUR |
| 148.72 Mio. EUR |
| 74.96 Mio. EUR |
| 58.84 Mio. EUR |
| 1.32 |
| 1% |
| -1135.07% |
| 0.1 EUR |
| 1.19% |
| 1.2% |
| 30.04.25 - 0.099451005€ 26.04.24 - 0.09041€ >weitere anzeigen... |
| - |
| VITROLIFE |
| 08.04.26 |
|